View text source at Wikipedia
HUPRA syndrome | |
---|---|
Other names | Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome |
HUPRA syndrome is inherited via autosomal recessive manner | |
Frequency | Less than one in a million |
HUPRA syndrome is a rare syndrome that was first described in 2010 in two infants of Palestinian origin from the same village in the Jerusalem area.[1] One of the two infants' parents were related.[1] It was later described in a third infant from the same village, whose parents were not related.[1]
The acronym stands for Hyperuricemia, Pulmonary hypertension, Renal failure in infancy and Alkalosis. And it's due to mutations in the mitochondrial SARS enzyme.[1] It is an autosomal recessive disease, that has a prevalence of less than one in a million.[2] One in fifteen of the village's inhabitants were found to carry the genetic mutation.[1]
Those affected were born prematurely, and suffered from feeding difficulties and developmental delays.[1] They presented with progressive kidney disease and primary pulmonary hypertension, and ultimately died.[1]
The cause of this condition is a mutation in the SARS2 gene (seryl-tRNA synthetase enzyme) which has to do with protein translation. Furthermore, the HUPRA syndrome is autosomal recessive in its inheritance pattern. It is located on chromosome 19 (19q13.2).[3][4]
This section is empty. You can help by adding to it. (July 2017) |
Currently there is no curative treatment.[citation needed]